Bridgewest Ventures
Status
ACTIVE
Global HQ
San Diego, United States
Countries of investment
- United States
- Europe
- Israel
- Australia
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Pharmaceuticals
- Diagnostics
- Medical Devices
- Software
- Semiconductor
About
Bridgewest Ventures leverages extensive life sciences operating experience to help founders develop, scale, and commercialize innovative healthcare solutions globally.
Bridgewest Ventures leverages extensive life sciences operating experience to help founders develop, scale, and commercialize innovative healthcare solutions globally.
Investment Thesis
Bridgewest Ventures invests in biotechnology, therapeutics, diagnostics, and healthcare technologies capable of addressing significant unmet medical needs. The thesis focuses on science-driven companies with the potential to create meaningful clinical and commercial impact.
Manager's Experience
Led by Masanori "Masa" Togawa and the broader Bridgewest Group leadership, the team combines biotech entrepreneurship, pharmaceutical development, and healthcare investing experience. They have built and scaled life sciences companies across therapeutics, diagnostics, and medical technology.
Bridgewest Ventures Contacts Information
Primary contact
Team
Masanori Togawa - Managing Director
life sciences investment professionals and operating executives from Bridgewest Group
Portfolio
Gyroscope Therapeutics
Avalyn Pharma
Kiora Pharmaceuticals
Biolinq
Truvian
Singular Genomics